IT IS THE OVERALL GOAL OF THIS PROJECT TO DEVELOP SENSITIVE IMMUNOLOGICAL ASSAYS FOR USE IN CLINICAL VIRAL DIAGNOSIS.

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1985
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
2916
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Innovative Technology, Inc.
Box 10072 Southern Station, Hattiesburg, MS, 39406
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
WILLARD L. DOUGLAS, JR.
PRINCIPAL INVESTIGATOR
(601) 266-4709
Business Contact:
() -
Research Institution:
n/a
Abstract
IT IS THE OVERALL GOAL OF THIS PROJECT TO DEVELOP SENSITIVE IMMUNOLOGICAL ASSAYS FOR USE IN CLINICAL VIRAL DIAGNOSIS. PHASE I ACTIVITIES WILL BE DEVOTED TO DEVELOPMENT OF A MICROWELL ASSAY SYSTEM BASED ON AN ASSAY PRINCIPLE KNOWN AS LIGAND REPLACEMENT (A TYPE OF HETEROGENEOUS, COMPETITIVE ASSAY) AND UTILIZING ENZYME-CYCLING DETECTION SYSTEMS TO ACHIEVE THE SENSITIVITY REQUIRED. AS A MODEL SYSTEM, WE WILL USE DENGUE-2 VIRUS AND MONOCLONAL ANTIBODIES AGAINST THIS STRAIN. MAJOR EMPHASIS WILL BE PLACED ON THE EVALUATION OF SEVERAL CYCLING SYSTEMS, ON THE PRODUCTION OF CONJUGATES OF VIRUS ANTIGEN WITH ENZYMES OR COENZYMES APPROPRIATE TO THE CYCLING SYSTEMS, AND ON EVALUATING THE EFFICACY OF THE LIGAND REPLACEMENT ASSAY FOR USE IN VIRAL DIAGNOSIS. SUCCESSFUL COMPLETION OF PHASE I ACTIVITIES WILL LEAD IN PHASE II TO EXPERIMENTS TO INCORPORATE ALL REAGENTS INTO A DRY FILM FORMAT SUITABLE FOR USE IN SMALL CLINICS AND PHYSICIANS' OFFICES. COMPLETION OF PHASE II WILL MAKE AVAILABLE HIGHLY SENSITIVE VIRUS DETECTION SYSTEMS WHICH CAN BE USED BOTH IN WELL-EQUIPPED CLINICAL LABORATORIES AS WELL AS SMALL CLINICS AND OTHER FIELD SITUATIONS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government